$1.58
-0.06-3.66%
Last update: Nov 9, 8:34 AM
ADC Therapeutics SA
ADCTNYSE
The average analyst price target for ADC Therapeutics is $5.75, 248.5% above the current price. Of 6 analysts, 3 rate it Buy and 3 Hold. Targets range from $2 to $8. The latest change came on Aug 17, 2026, when Guggenheim lowered its price target on ADC Therapeutics from $10 to $5 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
